Although there are issues with waning immunity, current COVID-19 vaccines offer excellent protection. But this might not always be the case. Future variant-specific boosters may preferentially boost responses to the original strain and be less effective.🧵 cell.com/trends/immunol…
The theory works like this: a person exposed to strain A of the virus (either by vaccination or infection) may prime their immune system such that the ability to make future antibodies specific to a future strain (strain B) is reduced.
This is known as immune imprinting.
In that scenario, a vaccine booster for strain B will give some protection against the new strain B, but the immune system will preferentially produce antibodies against the original strain A.
It is possible that immune imprinting will not turn out to be a significant problem with SARS-CoV-2, and/or it may be possible to design better vaccines that limit this issue.
While the authors of the article linked to at the start of this thread hope that immune imprinting will not be a major problem, they warn that we must take the possibility of future problems seriously.
It’s very important to understand that this is NOT an argument against vaccination.
Immune imprinting also occurs with infection (and you get COVID-19 as well).
Vaccination remains extremely important. Everyone should get vaccinated if they have the opportunity.
However, we need to think about how we can get the most benefit out of the vaccines we have today.
That means we mustn’t rely on vaccines alone to end the pandemic. We need a #VaccinesPlus strategy: vaccination plus some ongoing (and hopefully unobtrusive) low-level mitigations.
We need to use vaccines PLUS things like ventilation improvements in our public buildings.
Improved sanitation was one of the greatest contributors to the increased life expectancy we enjoy today. Nowadays, clean water is taken for granted in most countries.
Today, we need to take the next step and ensure that everyone has access to clean air.
This will reduce transmission of SARS-CoV-2, and also protect us from future pandemics.
It’s very unlikely that we will completely eradicate SARS-CoV-2, because the virus has animal reservoirs.
But we can keep transmission to low levels with a #VaccinesPlus strategy.
This will save lives, protect economies, and reduce the risk of new variants emerging.
By reducing the risk of new variants emerging, we can also lower the risk of running into problems with immune imprinting. This will ensure that we can depend on vaccines to deliver a high level of protection into the future.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Study of people with mild or moderate (but not hospitalised) COVID-19 from the first wave in Geneva. 7-9 months later, at least 25% had >=1 persisting symptom. Most common: fatigue (14%); loss of smell/taste (11%); headache (7%); shortness of breath (8%). acpjournals.org/doi/10.7326/M2…
Note: These proportions were calculated using the entire study sample as the denominator. However, one-third of people were lost to follow-up and their health status was unknown. It’s therefore possible that the proportion of people experiencing persistent symptoms was higher.
Of those with fatigue, 27% said they were limited in strenuous activity. 60% of those with shortness of breath experienced this when walking up a slight hill or when hurrying. Most people with headache or loss of smell or taste reported at least moderate symptoms.
The authors suggest two theories for this, both of which could be true.
First, certain mutations could "unlock" new space for further mutations to occur. This seems quite likely: the virus has only just started to adapt to humans
Second, selection pressure could be driving an increase in mutations. Think of the first wave in Manaus, Brazil, where people thought herd immunity had been reached. A second wave followed, as the virus evaded immunity and got better at infecting people.
In contrast to other parts of Australia, the NSW government refused to lockdown when the delta variant was first detected in the community, and implemented restrictions only grudgingly.
The contrast between NSW and where I live speaks volumes.
We have no known transmission.
Unfortunately, I fear the negligence of the NSW government will affect us eventually.
It will be harder to keep COVID-19 out now, and we still have many people to vaccinate.
This is the second major problem we face. Our cheapskate federal government didn’t buy enough vaccines.
At what level of vaccination can Australia safely reopen?
With 70% of adults vaccinated, expect:
📈 6.9 million cases
🏥 154,000 hospitalisations
☠️ 29,000 deaths
At 80%:
☠️ 25,000 deaths
🤒 270,000 people with long COVID
We need >90%, including children, to be safe. #auspol
Children & adolescents must be included to reopen safely. If we don’t vaccinate them we can expect thousands of deaths from vaccine breakthrough infections.
Children also benefit directly from vaccination.
75% vaccination in children would prevent 12,000 child hospitalisations.
These figures are the results of new modelling produced by @GraftonQuentin, @Tom_Kompas, John Parslow, & me.
We explored what would happen when the final stage of the National Plan is reached, where it’s proposed to manage COVID-19 like flu.
Study of vaccine effectiveness in New York (51% received Pfizer-BNT, 40% Moderna, and 9% J&J). Protection against symptomatic infection decreased over 3 months from 92% to 80% (likely delta variant effect) but hospitalisation protection maintained at ~95%. cdc.gov/mmwr/volumes/7…
During the course of the study, the prevalence of the delta variant increased from <2% to more than 80% in the area in which the study was conducted.
This seems like the most likely reason for the decrease in effectiveness against symptomatic infection.
This study demonstrates the importance of continuing public health measures, such as improving ventilation and using masks in public places, until very high levels of vaccination are achieved in the population.
The authors also state that "[r]outine vaccination of well teenagers aged 12–15 years adds little to the reduction in COVID-19 transmission through the community."
This is false.
While there is some debate about how much children transmit, adolescents transmit just like adults.